<?xml version="1.0" encoding="UTF-8"?>
<p>The availability of calcium supplements must be ensured for patients with hypoparathyroidism to prevent life-threatening complications of hypocalcemia. Patients with hypoparathyroidism should have access to their endocrine service provider if they develop symptoms of hypocalcemia, and advice regarding management should be given based on the symptoms and signs, pending laboratory confirmation of hypocalcemia. For patients with hyperparathyroidism awaiting surgery, timing of parathyroid surgery must be considered based on the risk profile of the patients and availability of surgical facilities.</p>
